| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/23/2010 | EP2197491A2 High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| 06/23/2010 | EP1525305B1 Methods and compositions for in vitro synthesis of proteins in a cell-free system enriched with atp-sulfurylase |
| 06/23/2010 | CN1876819B Genetically engineered duckweed |
| 06/23/2010 | CN1871351B Novel fungal proteins and nucleic acids encoding same |
| 06/23/2010 | CN1871256B Muteins of tear lipocalin |
| 06/23/2010 | CN1837237B Recombinant human interleukin1 receptor antagon (rhIL-1ra) with low pyrogen and its high efficiency preparation process |
| 06/23/2010 | CN1625596B Transcriptional factor, transcriptional factor gene and uses thereof |
| 06/23/2010 | CN101755054A Process for producing exogenous protein in the milk of transgenic mammals |
| 06/23/2010 | CN101748182A Preparation method of oryzenin antioxidant peptide |
| 06/23/2010 | CN101748181A Method for preparing high-ferric content ferroheme polypeptide composite with pepsin hydrolysis method |
| 06/23/2010 | CN101748180A Functional peanut small molecule mixed polypeptide, preparation method and application thereof |
| 06/23/2010 | CN101748179A Preparation method of feather protein peptide |
| 06/23/2010 | CN101748167A Method for improving fermentation efficiency by using fermentation tail gas |
| 06/23/2010 | CN101748145A Recombinant yeast for expressing antibody or antibody analogue as well as construction method and application thereof |
| 06/23/2010 | CN101748078A Novel Bacillus amyloliquefaciens strain and application thereof |
| 06/23/2010 | CN101748076A Method for preparing personalized biological culture medium raw material from beer waste yeast |
| 06/23/2010 | CN101747416A B-cell antigenic multi-epitope peptide linked in tandem in OmpU of vibrio mimicus, making method and application thereof |
| 06/23/2010 | CN101747408A Technology for producing polypeptide-Fe through taking animal blood as raw material |
| 06/23/2010 | CN101744845A Chlorella extractive composition and preparation method thereof |
| 06/23/2010 | CN101100689B Method for preparing pearl active peptide |
| 06/22/2010 | US7741466 Cellulase for use in conversion of cellulosic feedstocks into ethanol; recombinant host cell |
| 06/22/2010 | US7741452 produced by introducing amino acid mutation(s) so that no glycosylation take place at at least one glycosylation site of hepatocyte growth factor; more stable in the blood circulation |
| 06/22/2010 | US7741448 produced by using a liposome containing a GM1 ganglioside at a predetermined ratio as an immunogen; Alzheimer's disease |
| 06/22/2010 | US7741447 Antibody against tumor specific antigen as target |
| 06/22/2010 | US7741444 Neoplasm specific antibodies and uses thereof |
| 06/22/2010 | US7741442 Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation |
| 06/22/2010 | US7741439 Isolated stra6 polypeptides |
| 06/22/2010 | US7741434 High-affinity antagonists of ELR-CXC chemokines |
| 06/22/2010 | US7741295 Detecting activity of a Silent information regulator 2 by combining the composition with adenosine 5'-diphosphate and an acetylated Sir2 peptide substrate to deacetylate the peptide, and identifying 2'/3'-O-acetyl-ADP-ribose in the mixture to determine the presence of Sir2 activity |
| 06/22/2010 | US7741282 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein |
| 06/22/2010 | US7741278 Modified proteins, designer toxins, and methods of making thereof |
| 06/22/2010 | US7741272 Inhibiting angiogenesis in a mammal by administering Eph receptor antagonist ; cardiovascular disorders |
| 06/22/2010 | US7741270 Luminescent markers |
| 06/22/2010 | US7741115 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells |
| 06/22/2010 | US7741101 converting 5'-xanthylic acid (XMP) to 5'-guanylic acid (GMP); accumulating GMP synthetase in a high concentration in a culture medium using the microbial strain |
| 06/22/2010 | US7741098 Plasmid vector for expression in caenorhabditis elegans and in escherichia coli; heterologous gene expression |
| 06/22/2010 | US7741092 Amylases, nucleic acids encoding them and methods for making and using them |
| 06/22/2010 | US7741089 Laccases, nucleic acids encoding them and methods for making and using them |
| 06/22/2010 | US7741088 producing a dehydrated immobilized enzyme catalyst having improved specific activity upon rehydration and use of the enzyme catalyst for the conversion of glycolonitrile to glycolic acid |
| 06/22/2010 | US7741083 Heat-treatment to produce glycolonitrile which is converted to ammonium glycolate using enzyme catalyst having nitrilase activity; low concentrations of impurities, high yield |
| 06/22/2010 | US7741082 Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor |
| 06/22/2010 | US7741079 Method of making a genetically modified mammalian cell |
| 06/22/2010 | US7741078 Heparin-binding protein modified with heparan sulfate sugar chains, process for producing the same and pharmaceutical compositions containing the same |
| 06/22/2010 | US7741077 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| 06/22/2010 | US7741076 developing genetic constructs capable of expressing lipidated rP6 in e coli; used for to preventing disease caused by Haemophilus influenzae |
| 06/22/2010 | US7741075 Pichia pastoris PIR1 secretion signal peptide for recombinant protein expression and Pichia pastoris PIR1 and PIR2 anchor domain peptides for recombinant surface display |
| 06/22/2010 | US7741074 Endoglucanases digest the cellulose polymer at random locations, opening it to attack by cellobiohydrolases which sequentially release molecules of cellobiose from the ends of the cellulose polymer |
| 06/22/2010 | US7741073 Plastidial targeting peptide |
| 06/22/2010 | US7741072 Polypeptide variants |
| 06/22/2010 | US7741071 Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells |
| 06/22/2010 | US7741056 Junctional Adhesion Molecule (JAM); treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer; antagonist of a native sequence STIgMA polypeptide |
| 06/22/2010 | US7741042 Method for preparing a DNA chip and use thereof |
| 06/22/2010 | US7741039 Postweaning multisystemic wasting syndrome virus from pigs |
| 06/22/2010 | US7740871 Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine |
| 06/22/2010 | US7740870 Group B Streptococcus antigens and corresponding DNA fragments |
| 06/22/2010 | US7740857 Administering an isolated peptide; variants, derivatives or structural equivalents of cupredoxins or cytochrome |
| 06/22/2010 | US7740853 Fcepsilon-pe chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same |
| 06/22/2010 | US7740851 Ultra high affinity neutralizing antibodies |
| 06/22/2010 | US7740844 have a high binding affinity to all five isoforms of human vascular endothelial growth factor (VEGF); for cancer, age-related macular degeneration (AMD), rheumatoid arthritis, and diabetic retinopathy |
| 06/22/2010 | US7740841 Therapeutic method for reducing angiogenesis |
| 06/22/2010 | US7740835 Using a Bifidobacterium as a gene delivery vector for a recombinant DNA in combination with an antitumor agent to tumor tissues under anaerobic conditions |
| 06/22/2010 | US7740834 Murine zcytor17 ligand polypeptides |
| 06/22/2010 | US7740830 Imaging, diagnosis and treatment of disease |
| 06/22/2010 | CA2454264C A method of producing insulinotropic glp-1 (7-36) polypeptide and/or glp-1 analogs |
| 06/22/2010 | CA2434067C Materials and methods relating to protein aggregation in neurodegenerative disease |
| 06/22/2010 | CA2337491C Human mink gene mutations associated with arrhythmia |
| 06/22/2010 | CA2267217C Thermostable dna polymerase from anaerocellum thermophilum |
| 06/22/2010 | CA2256483C P13 lipid kinase |
| 06/22/2010 | CA2231784C Plasmid stabilization |
| 06/22/2010 | CA2216963C Tie-2 ligands, methods of making and uses thereof |
| 06/22/2010 | CA2175893C Protein tyrosine kinases named rse |
| 06/22/2010 | CA2122745C Bifunctional glycoproteins having a modified carbohydrate complement, and their use in tumor-selective therapy |
| 06/17/2010 | WO2010067801A1 RICE PANICLE BLAST RESISTANCE GENE Pb1 AND USE THEREOF |
| 06/17/2010 | WO2010067611A1 ANTIBODY AGAINST N-TERMINAL REGION OF β-CHAIN OF HEMOGLOBIN |
| 06/17/2010 | WO2010067563A1 Process for producing glycopeptide |
| 06/17/2010 | WO2007047773A9 Alanine 2,3-aminomutases and related polynucleotides |
| 06/17/2010 | US20100154081 Methods and means for producing glycoproteins with altered glycosylation pattern in higher plants |
| 06/17/2010 | US20100152419 Fusion protein containing highly-expressed and secreted insulin precursor, dna encoding same, and method of producing insulin |
| 06/17/2010 | US20100152418 Switch-Peptides as Tool for the Study of Fibrillogenesis |
| 06/17/2010 | US20100152092 Serine protease for enhancing washing performance of detergents; laundry and dishwashing; isolated from Bacillus strains; expression vectors, recombinant host cells |
| 06/17/2010 | US20100151589 Glycoproteins Having Lipid Mobilising Properties and Therapeutic Applications Thereof |
| 06/17/2010 | US20100151525 Method for extracting hydrophobin from a solution |
| 06/17/2010 | US20100151524 Compositions and Methods for Increasing Bone Mineralization |
| 06/17/2010 | US20100151523 Regulated expression of recombinant proteins from adeno-associated viral vectors |
| 06/17/2010 | US20100151522 Process For Producing Recombinant Fibrinogen Highly Producing Cell and Highly Producing Cell |
| 06/17/2010 | US20100151521 Method for Stable Gene-Amplification in a Bacterial Host Cell |
| 06/17/2010 | US20100151520 Translation Enhancer Elements Of Genes Encoding Human Tau Protein and Human Alpha-Synuclein Protein |
| 06/17/2010 | US20100151519 Method for production of isoprenoids |
| 06/17/2010 | US20100151518 Vectors and methods for enzyme production |
| 06/17/2010 | US20100151517 Methods for carrying out the selective evolution of proteins in vivo |
| 06/17/2010 | US20100151516 Gene SMS 13 |
| 06/17/2010 | US20100151515 Microbial trypsin mutants having chymotrypsin activity and nucleic acids encoding same |
| 06/17/2010 | US20100151514 substitute substance for human mucin and is useful in fields such as pharmaceutical, agricultural, and food fields; easily in large amounts from jellyfishes and is therefore superior as economical and environmental preservation techniques; accurate determination of the molecular weights |
| 06/17/2010 | US20100151499 Proteolytic release of glycans |
| 06/17/2010 | US20100151481 Cell-signaling assays |
| 06/17/2010 | US20100151476 Phenylthiocarbamide (ptc) taste receptor |
| 06/17/2010 | US20100151111 Polypeptides of Strain Bacillus SP. P203 |
| 06/17/2010 | US20100151097 Optimization of colicin production |
| 06/17/2010 | US20100151096 Inhibition of ice crystal growth |
| 06/17/2010 | US20100150998 Vaccines for malaria |